BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hass P, Mohnike K, Kropf S, Brunner TB, Walke M, Albers D, Petersen C, Damm R, Walter F, Ricke J, Powerski M, Corradini S. Comparative analysis between interstitial brachytherapy and stereotactic body irradiation for local ablation in liver malignancies. Brachytherapy 2019;18:823-8. [PMID: 31522972 DOI: 10.1016/j.brachy.2019.08.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Major T, Fröhlich G, Ágoston P, Polgár C, Takácsi-Nagy Z. The value of brachytherapy in the age of advanced external beam radiotherapy: a review of the literature in terms of dosimetry. Strahlenther Onkol 2021. [PMID: 34724086 DOI: 10.1007/s00066-021-01867-1] [Reference Citation Analysis]
2 Roussakis Y, Anagnostopoulos G. Physical and Dosimetric Aspects of the Iridium-Knife. Front Oncol 2021;11:728452. [PMID: 34858815 DOI: 10.3389/fonc.2021.728452] [Reference Citation Analysis]
3 Duque AS, Corradini S, Kamp F, Seidensticker M, Streitparth F, Kurz C, Walter F, Parodi K, Verhaegen F, Ricke J, Belka C, Fonseca GP, Landry G. The dosimetric impact of replacing the TG-43 algorithm by model based dose calculation for liver brachytherapy. Radiat Oncol 2020;15:60. [PMID: 32151255 DOI: 10.1186/s13014-020-01492-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
4 Appalanaido GK, Shukor SA, Fan AS, Chong SE, Hussin H, Karim NKA, Meng LV, Aziz MZA. Palliative brachytherapy to axilla and hypopharynx in elderly patient with hypopharyngeal squamous cell carcinoma - case report. Rep Pract Oncol Radiother 2021;26:647-53. [PMID: 34434581 DOI: 10.5603/RPOR.a2021.0076] [Reference Citation Analysis]
5 Boldrini L, Romano A, Mariani S, Cusumano D, Catucci F, Placidi L, Mattiucci GC, Chiloiro G, Cellini F, Gambacorta MA, Indovina L, Valentini V. MRI-guided stereotactic radiation therapy for hepatocellular carcinoma: a feasible and safe innovative treatment approach. J Cancer Res Clin Oncol 2021;147:2057-68. [PMID: 33398447 DOI: 10.1007/s00432-020-03480-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Yoon SM, Suh R, Abtin F, Moghanaki D, Genshaft S, Kamrava M, Drakaki A, Liu S, Venkat P, Lee A, Chang AJ. Outcomes with multi-disciplinary management of central lung tumors with CT-guided percutaneous high dose rate brachyablation. Radiat Oncol 2021;16:99. [PMID: 34098977 DOI: 10.1186/s13014-021-01826-1] [Reference Citation Analysis]
7 Walter F, Nierer L, Rottler M, Duque AS, Weingandt H, Well J, Shpani R, Landry G, Seidensticker M, Streitparth F, Ricke J, Belka C, Corradini S. Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma. Radiat Oncol 2021;16:86. [PMID: 33957941 DOI: 10.1186/s13014-021-01812-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Damm R, Pech M, Cavalli P, Haag F, Gylstorff S, Omari J, Thormann M, Seidensticker R, Ricke J, Seidensticker M, Relja B. Correlation of chemokines and growth factors with radiation-induced liver injury after interstitial high dose rate (HDR) brachytherapy of liver metastases. J Cancer Res Clin Oncol 2022. [PMID: 35596772 DOI: 10.1007/s00432-022-04041-x] [Reference Citation Analysis]
9 Rogowski P, von Bestenbostel R, Walter F, Straub K, Nierer L, Kurz C, Landry G, Reiner M, Auernhammer CJ, Belka C, Niyazi M, Corradini S. Feasibility and Early Clinical Experience of Online Adaptive MR-Guided Radiotherapy of Liver Tumors. Cancers (Basel) 2021;13:1523. [PMID: 33810244 DOI: 10.3390/cancers13071523] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
10 Mohindra P, Beriwal S, Kamrava M. Proposed brachytherapy recommendations (practical implementation, indications, and dose fractionation) during COVID-19 pandemic. Brachytherapy 2020;19:390-400. [PMID: 32423787 DOI: 10.1016/j.brachy.2020.04.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Duque AS, van Wagenberg T, Seidensticker M, Streitparth F, Walter F, Parodi K, Verhaegen F, Ricke J, Belka C, Paiva Fonseca G, Corradini S, Landry G. Validation of the collapsed cone algorithm for HDR liver brachytherapy against Monte Carlo simulations. Brachytherapy 2021;20:936-47. [PMID: 34001415 DOI: 10.1016/j.brachy.2021.03.018] [Reference Citation Analysis]
12 Scafa D, Muedder T, Holz JA, Koch D, Nour Y, Garbe S, Gonzalez-Carmona MA, Feldmann G, Vilz TO, Köksal M, Giordano FA, Schmeel LC, Sarria GR. Dosimetric Comparison of Intraoperative Radiotherapy and SRS for Liver Metastases. Front Oncol 2021;11:767468. [PMID: 34926271 DOI: 10.3389/fonc.2021.767468] [Reference Citation Analysis]
13 Appalanaido GK, Bahajjaj SIBZ, Shukor SA, Ahmad MZ, Francis HCH. Case Report-Staged brachytherapy achieving complete metabolic response in unresectable oligometastatic colorectal cancer to the liver. Oxf Med Case Reports 2021;2021:omab016. [PMID: 33948189 DOI: 10.1093/omcr/omab016] [Reference Citation Analysis]